Kimberly Grandinetti, M.D., FAAP
Timothy Crum, M.D., FAAP
Kristin Edgehouse, D.O., FAAP
Veronica Jessick, M.D.
315 W 9th Ave, Suite 200, Spokane, WA 99204
Fax (509) 290-6820
RSV/Flu/COVID
RSV Immunization for Children 19 months and Younger
​
-
Nirsevimab is recommended for infants younger than 8 months of age who were born during or are entering their first RSV season if
-
The mother did not receive RSV vaccine during pregnancy.
-
The mother’s RSV vaccination status is unknown.
-
The infant was born within 14 days of maternal RSV vaccination.
-
Most infants whose mothers got the RSV vaccine don’t need to get nirsevimab, too.
-
​
-
Some infants and young children 8 through 19 months of age who are at increased risk for severe RSV disease should receive nirsevimab shortly before the start of their second RSV season:
-
Children who were born prematurely and have chronic lung disease
-
Children with severe immunocompromise
-
Children with cystic fibrosis who have severe disease
-
American Indian and Alaska Native children
-
FLU and COVID Fall 2023 Boosters
We are also offering the most recent booster Pfizer COVID-19 Vaccine for children aged 6 months and older, along with Moderna Spikevax for 12 years old to 18 years old. You may call to schedule your Flu and COVID vaccines for ages 6 months and older by calling the office.
Please note, we are currently only able to vaccinate our patients.
For the most current recommendations and guidelines, go to:
COVID-19 | Washington State Department of Health
​
EUA Vaccine Safety Information for Pfizer COVID-19 Vaccine in 6 months to 4 years old
EUA Vaccine Safety Information for Pfizer COVID-19 Vaccine in 5-11 year olds
EUA Vaccine Safety information for Pfizer COVID-19 Vaccine for ages 12 and up
V-safe Enrollment Instructions
​
We currently offer rapid antigen testing at our clinic as well as influenza A and B and Strep.
​
Please call to schedule!